From the newsletter
The WHO and the African Medicines Agency have launched a deal to harmonise pharma markets regulation in Africa. Eduardo Carvalho, a Senior Pharma Executive with experience at GSK and Merck, says that Africa must still overcome deep structural barriers that have limited similar efforts for more than a decade.
He argues that achieving a truly harmonised medicines market will require countries to overcome uneven regulatory capacity, dependence on regulatory fees, concerns over national sovereignty, major gaps in technical regulatory infrastructure. He outlines how to overcome them and how a single pharma market should look like.
“The question is not whether harmonisation is necessary. It clearly is. The real question is whether Africa can overcome the structural barriers that have slowed similar initiatives for more than a decade,” says Mr Carvalho.
More details